RIO DE JANEIRO — Brazil’s health regulator on Sunday approved the urgent use of coronavirus vaccines made by Sinovac and AstraZeneca, enabling Latin America’s largest nation to begin an immunization program that’s been subject to months of delay and political disputes.

Brazil currently has 6 million doses of Sinovac’s